Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease

J Immunol. 2009 Jan 15;182(2):934-47. doi: 10.4049/jimmunol.182.2.934.

Abstract

A critical issue during severe respiratory infection is whether it is the virus or the host response that does the most damage. In this study, we show that endogenous 4-1BBL plays a critical role in protecting mice from severe effects of influenza disease. During mild respiratory influenza infection in which virus is rapidly cleared, the inducible costimulatory receptor 4-1BB is only transiently induced on lung T cells and 4-1BB ligand (4-1BBL) is completely dispensable for the initial CD8 T cell response and mouse survival. In contrast, during more severe respiratory influenza infection with prolonged viral load, 4-1BB expression on lung CD8 T cells is sustained, and 4-1BBL-deficient mice show decreased CD8 T cell accumulation in the lungs, decreased viral clearance, impaired lung function, and increased mortality. Transfer of an optimal number of naive Ag-specific T cells before infection protects wild-type but not 4-1BBL-deficient mice from an otherwise lethal dose of influenza virus. Transfer of T cells lacking the proapoptotic molecule Bim extends the lifespan of 4-1BBL-deficient mice by one to three days, suggesting that at least part of the role of 4-1BB/4-1BBL is to prolong effector cell survival long enough to clear virus. Intranasal delivery of 4-1BBL by recombinant adenovirus marginally improves survival of 4-1BBL-deficient mice at low dose, but exacerbates disease at high dose. These findings suggest a rationale for the evolutionary accumulation of inducible costimulatory molecules, thereby allowing the immune system to sustain the expression of molecules such as 4-1BB to a level commensurate with severity of infection.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 4-1BB Ligand / biosynthesis
  • 4-1BB Ligand / deficiency
  • 4-1BB Ligand / genetics
  • 4-1BB Ligand / physiology*
  • Administration, Intranasal
  • Animals
  • Epitopes, T-Lymphocyte / analysis
  • Epitopes, T-Lymphocyte / immunology
  • Gene Expression Regulation / immunology
  • Immunodominant Epitopes / analysis
  • Immunodominant Epitopes / immunology
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza A Virus, H1N1 Subtype / pathogenicity
  • Influenza A Virus, H3N2 Subtype / immunology*
  • Influenza A Virus, H3N2 Subtype / pathogenicity
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Orthomyxoviridae Infections / immunology*
  • Orthomyxoviridae Infections / mortality
  • Orthomyxoviridae Infections / physiopathology
  • Orthomyxoviridae Infections / prevention & control*
  • Pneumonia, Viral / immunology
  • Pneumonia, Viral / prevention & control
  • Pneumonia, Viral / virology
  • Respiratory Function Tests
  • Severity of Illness Index
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / biosynthesis
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / genetics
  • Tumor Necrosis Factor Receptor Superfamily, Member 9 / physiology
  • Virulence

Substances

  • 4-1BB Ligand
  • Epitopes, T-Lymphocyte
  • Immunodominant Epitopes
  • Tumor Necrosis Factor Receptor Superfamily, Member 9